|
More Information on the ChallengeRegister for the Challenge Here |
The Channelchek Equity Research College Challenge on the NASDAQ Tower
Take it to the next level. It doesn’t cost a penny.
Join the Channelchek Investor Community. Your name, email, zip, and investor type is all it takes to open the door to research reports, favorites tracking, and virtual and in-person roadshows / conferences. Even exclusive investment opps.
‌
Welcome to the Channelchek Investor Community
We’ve updated the entire site to bring you faster navigation and increased content at every level. Channelchek is now North America’s leading platform for access to regulated and independent company sponsored equity research.
Don't have an account? Join
Forgot passwordBy clicking “Log In” you agree to Channelchek.com Terms of Use and acknowledge that Channelchek.com Privacy Policy applies to you.
Related News
‌
3/1/2024
Health
Release – GeoVax Reports 2023 Year-End Financial Results and Provides Business Update
GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced its financial results and key operational accomplishments for the year ended...
10 min read
‌
3/1/2024
Media and Marketing
Release – Direct Digital Holdings to Report Fourth Quarter & Full Year 2023 Financial Results
Direct Digital Holdings, Inc. (Nasdaq: DRCT) (“Direct Digital Holdings” or the “Company”), a leading advertising and marketing technology platform operating through its companies Colossus Media, LLC (“Colossus SSP”), Huddled Masses...
2 min read
‌
3/1/2024
Natural Resources
Labrador Gold Corp. (NKOSF) – Putting a Spotlight on the Hopedale Project
Labrador Gold investor webinar. Labrador Gold recently hosted an investor webinar to discuss its Hopedale Project, a district-scale gold and critical metals property in Labrador that covers a 43-kilometer strike length...
2 min read
‌
3/1/2024
Financial Services
GeoVax Labs (GOVX) – FY2023 Reported With A Review Of Clinical Progress and Upcoming Milestones
Full Year Loss Was Less Than Expected. GeoVax reported a FY2023 loss of $26.0 million or $(14.29) per share, adjusted for a 1-for-15 reverse split in January 2024. The loss for...
3 min read
Inbox Intel from Channelchek.
Informed investors make more money. And it’s all about timing. Get it when it happens.